Jim Cramer, the host of CNBC’s “Mad Money,” is known for his energetic and often controversial takes on the stock market.

SkyBridge Capital founder Anthony Scaramucci, a headline speaker at Benzinga’s Future of Digital Assets event, is actively ...

Novo Nordisk announced Phase 2a trial results for monlunabant. The trial demonstrated a weight reduction of 7.1 kg with a 10 ...

Trump's ownership of a media company and publicly traded company is raising ethics concerns ahead of the 2024 election.

Mullen team present in Dubai this week for delivery of first EV vehicles. Mullen recently executed a 1-for-100 reverse stock ...

Microsoft announces the end of its Xbox Ambassadors program after 13 years, with the website shutting down Oct. 15.

Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose.

The union members, most of them based in Washington state, turned down a proposal to raise wages by 25% over four years, as ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $14.8, a high ...

KarXT, a novel schizophrenia drug, is on the verge of FDA approval, promising to revolutionize treatment. However, access ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Gartner IT has outperformed the market over the past 15 years by 13.06% on an annualized basis producing an average annual ...